• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VPAC1受体第三螺旋中的Asn229对于受体激活至关重要,但对于受体磷酸化和内化并非必需:与VPAC2受体中的Asn216进行比较。

Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.

作者信息

Nachtergael Ingrid, Gaspard Nathalie, Langlet Christelle, Robberecht Patrick, Langer Ingrid

机构信息

Department of Biological Chemistry and Nutrition, Faculty of Medicine, Université Libre de Bruxelles, Belgium.

出版信息

Cell Signal. 2006 Dec;18(12):2121-30. doi: 10.1016/j.cellsig.2006.03.006. Epub 2006 Mar 27.

DOI:10.1016/j.cellsig.2006.03.006
PMID:16650965
Abstract

After stimulation with agonist, G protein coupled receptors (GPCR) undergo conformational changes that allow activation of G proteins to transduce the signal, followed by phosphorylation by kinases and arrestin binding to promote receptor internalization. Actual paradigm, based on a study of GPCR-A/rhodopsin family, suggests that a network of interactions between conserved residues located in transmembrane (TM) domains (mainly TM3, TM6 and TM7) is involved in the molecular switch leading to GPCR activation. We evaluated in CHO cells expressing the VPAC(1) receptor the role of the third transmembrane helix in agonist signalling by point mutation into Ala of the residues highly conserved in the secretin-family of receptors: Y(224), N(229), F(230), W(232), E(236), G(237), Y(239), L(240). N(229)A VPAC(1) mutant was characterized by a decrease in both potency and efficacy of VIP stimulated adenylate cyclase activity, by the absence of agonist stimulated Ca(2+) increase, by a preserved receptor recognition of agonists and antagonist and by a preserved sensitivity to GTP suggesting the importance of that residue for efficient G protein activation. N(229)D mutant was not expressed at the membrane, and the N(229)Q with a conserved mutation was less affected than the A mutant. Agonist stimulated phosphorylation and internalization of N(229)A and N(229)Q VPAC(1) were unaffected. However, the re-expression of internalized mutant receptors, but not that of the wild type receptor, was rapidly reversed after VIP washing. Receptor phosphorylation, internalization and re-expression may be thus dissociated from G protein activation and linked to another active conformation that may influence its trafficking. Mutation of that conserved amino acid in VPAC(2) could be investigated only by a conservative mutation (N(216)Q) and led to a receptor with a low VIP stimulation of adenylate cyclase, receptor phosphorylation and internalization. This indicated the importance of the conserved N residue in the TM3 of that family of receptors.

摘要

在用激动剂刺激后,G蛋白偶联受体(GPCR)会发生构象变化,从而激活G蛋白以转导信号,随后通过激酶磷酸化以及与抑制蛋白结合来促进受体内化。基于对GPCR - A/视紫红质家族的研究,实际范例表明位于跨膜(TM)结构域(主要是TM3、TM6和TM7)的保守残基之间的相互作用网络参与了导致GPCR激活的分子开关。我们在表达VPAC(1)受体的CHO细胞中,通过将受体分泌素家族中高度保守的残基突变为丙氨酸来评估第三跨膜螺旋在激动剂信号传导中的作用:Y(224)、N(229)、F(230)、W(232)、E(236)、G(237)、Y(239)、L(240)。N(229)A VPAC(1)突变体的特征在于VIP刺激的腺苷酸环化酶活性的效力和功效均降低,激动剂刺激的[Ca(2+)]i增加缺失,激动剂和拮抗剂的受体识别得以保留,对GTP的敏感性得以保留,这表明该残基对有效的G蛋白激活很重要。N(229)D突变体未在细胞膜上表达,具有保守突变的N(229)Q比A突变体受影响更小。激动剂刺激的N(229)A和N(229)Q VPAC(1)的磷酸化和内化未受影响。然而,内化的突变体受体重新表达,但野生型受体未重新表达,在VIP洗脱后迅速逆转。因此,受体磷酸化、内化和重新表达可能与G蛋白激活解离,并与另一种可能影响其转运的活性构象相关联。VPAC(2)中该保守氨基酸的突变只能通过保守突变(N(216)Q)进行研究,结果产生了一种对腺苷酸环化酶、受体磷酸化和内化的VIP刺激较低的受体。这表明该受体家族TM3中保守的N残基很重要。

相似文献

1
Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.VPAC1受体第三螺旋中的Asn229对于受体激活至关重要,但对于受体磷酸化和内化并非必需:与VPAC2受体中的Asn216进行比较。
Cell Signal. 2006 Dec;18(12):2121-30. doi: 10.1016/j.cellsig.2006.03.006. Epub 2006 Mar 27.
2
Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor.失活突变对人VPAC2受体磷酸化及内化的影响。
J Mol Endocrinol. 2005 Apr;34(2):405-14. doi: 10.1677/jme.1.01717.
3
Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.乙酰组氨酸1 [D-苯丙氨酸2、赖氨酸15、精氨酸16、亮氨酸27] 血管活性肠肽 (3-7)/生长激素释放因子 (8-27)——一种VPAC1受体拮抗剂——对两种组成型活性截短型VPAC1受体起反向激动剂作用。
Peptides. 2004 Nov;25(11):1943-9. doi: 10.1016/j.peptides.2004.06.001.
4
Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.人VPAC1受体羧基末端的丝氨酸447对激动剂诱导的脱敏至关重要,但对受体的内化并不重要。
Mol Pharmacol. 2003 Dec;64(6):1565-74. doi: 10.1124/mol.64.6.1565.
5
Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2).共表达两种血管活性肠肽受体(hVPAC1和hVPAC2)的中国仓鼠卵巢细胞的药理学特性
Br J Pharmacol. 2006 Aug;148(8):1051-9. doi: 10.1038/sj.bjp.0706816. Epub 2006 Jun 19.
6
Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation.人重组VPAC1受体第三个细胞内环羧基末端的突变会损害血管活性肠肽(VIP)刺激的细胞内钙离子浓度([Ca2+]i)升高,但不会损害腺苷酸环化酶的刺激作用。
Cell Signal. 2005 Jan;17(1):17-24. doi: 10.1016/j.cellsig.2004.05.009.
7
Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.人血管活性肠肽受体亚型VPAC(2)的突变分析:第二个跨膜螺旋中碱性残基的作用
Br J Pharmacol. 2001 Aug;133(8):1249-54. doi: 10.1038/sj.bjp.0704195.
8
Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.一种新型VPAC(1)选择性激动剂的表征以及参与羧基末端肽识别的受体结构域的鉴定。
Br J Pharmacol. 2000 Jun;130(4):819-26. doi: 10.1038/sj.bjp.0703384.
9
Mutation of the phosphorylatable residue Thr429 in Glu of the human VPAC1 led to a constitutively desensitized receptor.人类血管活性肠肽1型受体(VPAC1)中谷氨酸的可磷酸化残基苏氨酸429发生突变,导致受体持续脱敏。
Peptides. 2006 Jul;27(7):1865-70. doi: 10.1016/j.peptides.2006.01.010. Epub 2006 Mar 22.
10
Evidence that interaction between conserved residues in transmembrane helices 2, 3, and 7 are crucial for human VPAC1 receptor activation.证据表明,跨膜螺旋 2、3 和 7 中的保守残基之间的相互作用对于人类 VPAC1 受体的激活至关重要。
Mol Pharmacol. 2010 Sep;78(3):394-401. doi: 10.1124/mol.110.063578. Epub 2010 Jun 23.

引用本文的文献

1
Novel Fluorescently Labeled PACAP and VIP Highlight Differences between Peptide Internalization and Receptor Pharmacology.新型荧光标记的促肾上腺皮质激素释放激素相关肽(PACAP)和血管活性肠肽(VIP)凸显了肽内化与受体药理学之间的差异。
ACS Pharmacol Transl Sci. 2022 Dec 8;6(1):52-64. doi: 10.1021/acsptsci.2c00124. eCollection 2023 Jan 13.
2
Signal Transduction by VIP and PACAP Receptors.血管活性肠肽和垂体腺苷酸环化酶激活肽受体介导的信号转导
Biomedicines. 2022 Feb 9;10(2):406. doi: 10.3390/biomedicines10020406.
3
Immune evasion by Salmonella: exploiting the VPAC1/VIP axis in human monocytes.
沙门氏菌的免疫逃逸:在人类单核细胞中利用 VPAC1/VIP 轴。
Immunology. 2019 Nov;158(3):230-239. doi: 10.1111/imm.13107. Epub 2019 Sep 11.
4
Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.三叉血管系统中的垂体腺苷酸环化酶激活多肽受体:与偏头痛的关系。
Br J Pharmacol. 2018 Nov;175(21):4109-4120. doi: 10.1111/bph.14053. Epub 2017 Oct 25.
5
Identification of potential therapeutic targets in a model of neuropathic pain.鉴定神经病理性疼痛模型中的潜在治疗靶点。
Front Genet. 2014 May 23;5:131. doi: 10.3389/fgene.2014.00131. eCollection 2014.
6
Caveolae-dependent internalization and homologous desensitization of VIP/PACAP receptor, VPAC₂, in gastrointestinal smooth muscle.胃肠道平滑肌中,小窝蛋白依赖的血管活性肠肽/垂体腺苷酸环化酶激活肽受体VPAC₂的内化及同源脱敏。
Peptides. 2013 May;43:137-45. doi: 10.1016/j.peptides.2013.03.008. Epub 2013 Mar 15.
7
Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies.涉及 VPAC 受体激活和调节的机制:来自药理学和突变研究的经验。
Front Endocrinol (Lausanne). 2012 Oct 30;3:129. doi: 10.3389/fendo.2012.00129. eCollection 2012.
8
Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.胰高血糖素样肽-1受体跨膜结构域中参与配体结合和受体激活的残基:构建配体结合受体模型
Mol Endocrinol. 2011 Oct;25(10):1804-18. doi: 10.1210/me.2011-1160. Epub 2011 Aug 25.
9
Conformational switches in the VPAC(1) receptor.VPAC(1) 受体的构象开关。
Br J Pharmacol. 2012 May;166(1):79-84. doi: 10.1111/j.1476-5381.2011.01616.x.